Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy
- 17 Downloads
With great interest, we read the article written by Freeman and colleagues about the implications of celiac disease (CeD) among patients undergoing a gastric bypass . The authors concluded that Roux-en-Y gastric bypass (RYGB) is safe for individuals with CeD. They reported on 68 patients who had abnormal serology or pathology prior to the operation, with only three individuals being diagnosed with CeD. However, acknowledging that CeD, and even celiac crisis, may be triggered following a surgery [2, 3]; it is important to know if among the 65 remaining patients with some abnormalities, new CeD cases were diagnosed after the bariatric surgery. We would also like to highlight “case 1,” a 42-year-old lady, non-adherent to the gluten-free diet (GFD), who lost 100% of excess weight in the first year after surgery. These questions were raised by a recent case of CeD at our institution, presenting with excessive weight loss 4 months after a single anastomosis duodeno-ileal...
The authors would like to thank Monika Shpokayte for proofreading the manuscript.
AT and ML wrote the letter. MPR and LD edited the letter. LMS interpreted the pathology slides. AT is the guarantor of the letter. All authors have approved the final letter.
Compliance with Ethical Standards
Conflict of Interest
The authors disclose no conflict of interest in relation to this work. Dr. Louise D’Aoust is on an advisory board for Shire for the use of teduglutide in short bowel syndrome. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Dr. Amelie Therrien was supported by phase 1 award from Fonds de Recherche Santé Québec (FRQS) Programme FRQS/MSSS de formation pour médecins résidents en médecine spécialisée visant une carrière en recherche.
The patient written informed consent was obtained for the publication of this letter.
- 4.Cuenca-Abente F, Nachman F, Bai JC. Diagnosis of celiac disease during pre-operative work-up for bariatric surgery. Acta Gastroenterol Latinoam. 2012;42(4):321–4.Google Scholar
- 15.Lau MS, Mooney PD, White WL, et al. The role of an IgA/IgG-deamidated gliadin peptide point-of-care test in predicting persistent villous atrophy in patients with celiac disease on a gluten-free diet. Am J Gastroenterol. 2017;112(12):1859–67. https://doi.org/10.1038/ajg.2017.357.CrossRefGoogle Scholar